Predicting Oncotype DX scores using clinicopathologic features: A report from the National Cancer Database.

被引：2
|
作者：
Pesce, Catherine
Kuchta, Kristine
Erdogan, Beyza
Wang, Chihsiung
Yao, Katharine
El-Tamer, Mahmoud
机构：
[1] NorthShore Univ Hlth Syst, Dept Surg, Evanston, IL USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
[3] NorthShore Univ HealthSyst, Evanston, IL USA
[4] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
551
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer
    Shibata, Akio
    Tamura, Nobuko
    Kinowaki, Keiichi
    Nishikawa, Aya
    Tanaka, Kiyo
    Kobayashi, Yoko
    Ogura, Takuya
    Tanabe, Yuko
    Kawabata, Hidetaka
    BREAST CANCER, 2024, 31 (06) : 1018 - 1027
  • [22] Comparative analyses of the prognostic value of oncotype and mammaprint using the National Cancer Database
    Ibraheem, A. F.
    Olopade, O.
    Huo, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [23] Trends in clinicopathologic features and systemic therapy use in breast cancer patients: Findings from the National Cancer Database
    Chagpar, Anees B.
    Mougalian, Sarah
    Lannin, Donald
    Abu-Khalaf, Maysa
    Killelea, Brigid
    Sanft, Tara
    Pusztai, Lajos
    CANCER RESEARCH, 2015, 75
  • [24] CLINICOPATHOLOGIC CHARACTERISTICS AND SURGICAL OUTCOMES OF PATIENTS WITH EARLY-ONSET COLORECTAL CARCINOMA: AN ANALYSIS OF THE NATIONAL CANCER DATABASE.
    Nfonsam, V.
    Khurrum, M.
    Hamidi, M.
    Cruz, A.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 119 - 119
  • [25] Disparities in the treatment of brain metastases from breast cancer: Insights from the National Cancer Database.
    Chahine, Zena
    Faisal, Muhammad Salman
    Jayakrishnan, Thejus Thayyil
    Abel, Stephen
    Wegner, Rodney E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Cost analysis of using Magee scores as a surrogate of Oncotype DX for adjuvant treatment decisions in women with early breast cancer
    de Lima, Mariana A. G.
    Clemons, Mark
    Van Katwyk, Sasha
    Stober, Carol
    Robertson, Susan J.
    Vandermeer, Lisa
    Fergusson, Dean
    Thavorn, Kednapa
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (03) : 889 - 892
  • [27] Can Oncotype DX testing be omitted in invasive breast cancer patients with clinicopathologic factors predicting very high pretest probability of a concordant result?
    Kapadia, Sonam
    Gudiwada, Sai Priyanka
    Kaji, Amy H.
    Chlebowski, Rowan T.
    Venegas, Rose
    Ozao-Choy, Junko
    Dauphine, Christine
    BREAST JOURNAL, 2020, 26 (11): : 2199 - 2202
  • [28] Secondary invasive breast events (SIBE) among patients with oncotype DX recurrence scores (RS) 26-30 and >31: Results from a large oncotype database
    Zimmerman, Brittney S.
    Cascetta, Krystal
    Berger, Natalie
    Tharakan, Serena
    Suchman, Kelly
    Blanter, Julia
    Moshier, Erin
    Ru, Meng
    Jaffer, Shabnam
    Tiersten, Amy
    CANCER RESEARCH, 2021, 81 (04)
  • [29] Breast cancer specific mortality in patients with early-stage hormone receptor-positive invasive breast cancer and oncotype DX recurrence score results in the SEER database.
    Shak, Steven
    Petkov, Valentina
    Miller, Dave P.
    Howlader, Nadia
    Gliner, Nathan
    Howe, Will
    Schussler, Nicola C.
    Cronin, Kathleen
    Baehner, Frederick L.
    Penberthy, Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [30] Clinicopathologic Features and Radiation Therapy Utilization in Patients with Male Breast Cancer: A National Cancer Database Study
    Weir, Joshua
    Zhao, Yan Daniel
    Herman, Terence
    Algan, Ozer
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2018, 12
12345